The current stock price of PRFX is 0.6952 USD. In the past month the price decreased by -33.58%. In the past year, price decreased by -78.49%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.23 | 1.00T | ||
| JNJ | JOHNSON & JOHNSON | 19.79 | 494.93B | ||
| MRK | MERCK & CO. INC. | 12.39 | 270.85B | ||
| PFE | PFIZER INC | 7.95 | 144.64B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.33 | 111.26B | ||
| ZTS | ZOETIS INC | 20.39 | 56.96B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.85 | 23.36B | ||
| VTRS | VIATRIS INC | 5.35 | 14.35B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.59 | 11.73B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.60B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.58B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 4.37B |
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PAINREFORM LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442 IL
CEO: Ilan Hadar
Employees: 2
Phone: 97237177051
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
The current stock price of PRFX is 0.6952 USD. The price increased by 2.61% in the last trading session.
PRFX does not pay a dividend.
PRFX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PRFX.
The outstanding short interest for PAINREFORM LTD (PRFX) is 3.28% of its float.
ChartMill assigns a fundamental rating of 2 / 10 to PRFX. PRFX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -32.16. The EPS increased by 81.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -130.69% | ||
| ROE | -172.78% | ||
| Debt/Equity | 0 |